Polygene Bio

BiotechnologyAngelBeijing, China

Latest round

Angel

Last raised

Mar 2026

Total raised

Undisclosed

Investors

1

About Polygene Bio

, trading as Polygene Bio, focuses on the research and development of next-generation hyperbranched polymers, specializing in highly efficient and stable transfection reagents and gene delivery. The company is committed to solving the pain point of traditional non-viral transfection reagents (such as liposomes and PEI) in achieving a balance between transfection efficiency and cytotoxicity, as well as the "bottleneck" problem of the long-standing monopoly of European and American companies in the domestic high-end core transfection reagent market. The company generates revenue by doing R&D, and providing upstream core materials and gene transfection reagents and other related services.

Who invested in Polygene Bio

1 investor across 1 round

See all investors in Polygene Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Mar 20, 2026

    Amount

    Undisclosed

    Investors

    Locked

Questions about Polygene Bio

Who invested in Polygene Bio?

Polygene Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Polygene Bio raised?

Polygene Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Polygene Bio last raise money?

Polygene Bio's most recent round on record is a Angel, in Mar 2026.

What does Polygene Bio do?

, trading as Polygene Bio, focuses on the research and development of next-generation hyperbranched polymers, specializing in highly efficient and stable transfection reagents and gene delivery.

Where is Polygene Bio headquartered?

Polygene Bio is headquartered in Beijing, China.

Which VCs invest in companies like Polygene Bio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Polygene Bio's stage. Their profiles are linked below.

Raising like Polygene Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.